Washington, D.C. — President Donald J. Trump announced that he will sign an executive order on Monday aimed at significantly reducing the cost of prescription drugs and pharmaceuticals in the United States. The executive action is part of the administration’s broader strategy to reform the healthcare system and make essential medications more affordable for millions of Americans.

Speaking from the White House, President Trump stated that the high cost of prescription drugs has placed an unfair burden on American families, particularly seniors and low-income individuals. He emphasized that pharmaceutical companies have enjoyed unchecked pricing power for too long, and that this order will help level the playing field for consumers.

“Americans pay more for prescription drugs than any other country in the world, and that’s going to change,” Trump said. “This executive order will take historic steps to bring fairness, competition, and lower prices to the pharmaceutical market.”

Although specific provisions of the order have not yet been fully disclosed, officials suggest it may include measures to allow for the importation of cheaper drugs from abroad, tie drug prices to those paid in other developed nations, and increase price transparency among manufacturers and providers.

The move has drawn a mixed response from lawmakers, industry leaders, and consumer advocates. Supporters applaud the effort to rein in drug prices, while critics caution that the changes could have unintended consequences, including impacts on innovation and pharmaceutical investment.

This executive order is expected to build on previous initiatives launched by the Trump administration, including efforts to eliminate rebates to pharmacy benefit managers and promote generic drug competition.

The order is scheduled to be signed on Monday, signaling what the administration describes as one of the most aggressive attempts to lower drug prices in recent history.